Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.18 USD | +0.42% |
|
+11.84% | +19.87% |
07-09 | BioCryst Pharmaceuticals Says Orladeyo Approved in Peru | MT |
07-03 | Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.87% | 1.48B | |
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
+149.98% | 12.37B |
- Stock Market
- Equities
- BCRX Stock
- News BioCryst Pharmaceuticals, Inc.
- Transcript : BioCryst Pharmaceuticals, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 08